164 related articles for article (PubMed ID: 26809240)
1. Early Candidate Biomarkers of Non-Small Cell Lung Cancer Are Screened and Identified in Premalignant Lung Lesions.
Nan Y; Du J; Ma L; Jiang H; Jin F; Yang S
Technol Cancer Res Treat; 2017 Feb; 16(1):66-74. PubMed ID: 26809240
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma.
Vermylen P; Roufosse C; Burny A; Verhest A; Bosschaerts T; Pastorekova S; Ninane V; Sculier JP
Eur Respir J; 1999 Oct; 14(4):806-11. PubMed ID: 10573225
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of differences in protein levels in normal, premalignant, and malignant lung cells and tissues using high-throughput Western Array and immunohistochemistry.
Shen J; Behrens C; Wistuba II; Feng L; Lee JJ; Hong WK; Lotan R
Cancer Res; 2006 Dec; 66(23):11194-206. PubMed ID: 17145864
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the expression protein profiles of lung squamous carcinoma cell using shot-gun proteomics strategy.
Nan Y; Yang S; Tian Y; Zhang W; Zhou B; Bu L; Huo S
Med Oncol; 2009; 26(2):215-21. PubMed ID: 18988000
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a set of biomarkers of human lung adenocarcinoma through cell-map proteomics and bioinformatics.
Nan Y; Jin F; Yang S; Tian Y; Xie Y; Fu E; Yu H
Med Oncol; 2010 Dec; 27(4):1398-406. PubMed ID: 20041319
[TBL] [Abstract][Full Text] [Related]
6. Identification of candidate biomarkers for early detection of human lung squamous cell cancer by quantitative proteomics.
Zeng GQ; Zhang PF; Deng X; Yu FL; Li C; Xu Y; Yi H; Li MY; Hu R; Zuo JH; Li XH; Wan XX; Qu JQ; He QY; Li JH; Ye X; Chen Y; Li JY; Xiao ZQ
Mol Cell Proteomics; 2012 Jun; 11(6):M111.013946. PubMed ID: 22298307
[TBL] [Abstract][Full Text] [Related]
7. Quantitative Secretomic Analysis Identifies Extracellular Protein Factors That Modulate the Metastatic Phenotype of Non-Small Cell Lung Cancer.
Hu R; Huffman KE; Chu M; Zhang Y; Minna JD; Yu Y
J Proteome Res; 2016 Feb; 15(2):477-86. PubMed ID: 26736068
[TBL] [Abstract][Full Text] [Related]
8. Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins.
Jin Y; Wang J; Ye X; Su Y; Yu G; Yang Q; Liu W; Yu W; Cai J; Chen X; Liang Y; Chen Y; Wong BH; Fu X; Sun H
Br J Cancer; 2016 Mar; 114(5):532-44. PubMed ID: 26908325
[TBL] [Abstract][Full Text] [Related]
9. Predicting Diagnostic Gene Biomarkers for Non-Small-Cell Lung Cancer.
Liang B; Shao Y; Long F; Jiang SJ
Biomed Res Int; 2016; 2016():3952494. PubMed ID: 27579312
[TBL] [Abstract][Full Text] [Related]
10. Differentially expressed and activated proteins associated with non small cell lung cancer tissues.
Nigro E; Imperlini E; Scudiero O; Monaco ML; Polito R; Mazzarella G; Orrù S; Bianco A; Daniele A
Respir Res; 2015 Jun; 16(1):74. PubMed ID: 26104294
[TBL] [Abstract][Full Text] [Related]
11. Expression of ER stress and autophagy-related molecules in human non-small cell lung cancer and premalignant lesions.
Kim KM; Yu TK; Chu HH; Park HS; Jang KY; Moon WS; Kang MJ; Lee DG; Kim MH; Lee JH; Chung MJ
Int J Cancer; 2012 Aug; 131(4):E362-70. PubMed ID: 21953091
[TBL] [Abstract][Full Text] [Related]
12. Application of proteomics in non-small-cell lung cancer.
Cho WC
Expert Rev Proteomics; 2016; 13(1):1-4. PubMed ID: 26577456
[TBL] [Abstract][Full Text] [Related]
13. Early detection of lung cancer by molecular markers in endobronchial epithelial-lining fluid.
Kahn N; Meister M; Eberhardt R; Muley T; Schnabel PA; Bender C; Johannes M; Keitel D; Sültmann H; Herth FJ; Kuner R
J Thorac Oncol; 2012 Jun; 7(6):1001-8. PubMed ID: 22588153
[TBL] [Abstract][Full Text] [Related]
14. Unique Protein Profiles of Extracellular Vesicles as Diagnostic Biomarkers for Early and Advanced Non-Small Cell Lung Cancer.
An T; Qin S; Sun D; Huang Y; Hu Y; Li S; Zhang H; Li B; Situ B; Lie L; Wu Y; Zheng L
Proteomics; 2019 Jun; 19(12):e1800160. PubMed ID: 30950185
[TBL] [Abstract][Full Text] [Related]
15. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G
World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827
[TBL] [Abstract][Full Text] [Related]
16. [Non-small cell lung cancer. New biomarkers for diagnostics and therapy].
Kayser G
Pathologe; 2015 Nov; 36 Suppl 2():189-93. PubMed ID: 26391246
[TBL] [Abstract][Full Text] [Related]
17. Chaperonin (HSP60) and annexin-2 are candidate biomarkers for non-small cell lung carcinoma.
Ağababaoğlu İ; Önen A; Demir AB; Aktaş S; Altun Z; Ersöz H; Şanl A; Özdemir N; Akkoçlu A
Medicine (Baltimore); 2017 Feb; 96(6):e5903. PubMed ID: 28178129
[TBL] [Abstract][Full Text] [Related]
18. [Expression of KAI1, MRP-1, and FAK proteins in lung cancer detected by high-density tissue microarray].
Wang XY; Liu T; Zhu CZ; Li Y; Sun R; Sun CY; Wang AX
Ai Zheng; 2005 Sep; 24(9):1091-5. PubMed ID: 16159431
[TBL] [Abstract][Full Text] [Related]
19. Myristoylated alanine-rich C-kinase substrate as a prognostic biomarker in human primary lung squamous cell carcinoma.
Hanada S; Kakehashi A; Nishiyama N; Wei M; Yamano S; Chung K; Komatsu H; Inoue H; Suehiro S; Wanibuchi H
Cancer Biomark; 2013; 13(4):289-98. PubMed ID: 24240590
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of focal adhesion kinase in non-small cell lung cancer.
Carelli S; Zadra G; Vaira V; Falleni M; Bottiglieri L; Nosotti M; Di Giulio AM; Gorio A; Bosari S
Lung Cancer; 2006 Sep; 53(3):263-71. PubMed ID: 16842883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
